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Abstract: Osteogenesis imperfecta (OI) is a heterogeneous heritable connective tissue disor-
der characterized by low bone density. The type and severity of OI are variable. The primary 
manifestations are fractures, bone deformity, and bone pain, resulting in reduced mobility and 
function to complete everyday tasks. OI affects not only the physical but also the social and 
emotional well-being of children, young people, and their families. As such, medical, surgical, 
and allied health professionals’ assessments all play a role in the management of these children. 
The multidisciplinary approach to the treatment of children and young people living with OI 
seeks to provide well-coordinated, comprehensive assessments, and interventions that place the 
child and family at the very center of their care. The coordinated efforts of a multidisciplinary 
team can support children with OI to fulfill their potential, maximizing function, independence, 
and well-being.
Keywords: physical therapy, occupational therapy, bisphosphonates, nursing, psychology, 
pediatrics 
Introduction
Evolution of the multidisciplinary team
Multidisciplinary team (MDT) management of complex, chronic diseases is an accepted 
part of clinical practice. In respect of the Metabolic Bone Disease Service at Shef-
field Children’s Hospital, the MDT approach began with the appointment of the UK’s 
first consultant in pediatric metabolic bone disease in October 1998, with the MDT 
commencing its work early in 1999. The original team comprised the consultant, a 
full-time clinical nurse specialist (CNS), a half-time physical therapist and a full-time 
occupational therapist. The original expectation was that the service would grow from 
its original caseload of ~25 patients to 125 patients by the end of 5 years and then 
plateau. In 2016, 17 years after the team’s inception, the caseload is ~500 patients, 
more than half of whom have osteogenesis imperfecta (OI). In 2011, Sheffield was 
one of four centers designated by NHS England to deliver a highly specialized service 
(HSS) for severe, complex, and atypical pediatric OI. Sheffield sees ~110 of the 280 
patients within this designated service. The size and scope of the MDT have increased 
steadily, adding psychology, social work, dentistry, and dietetics to the core services. 
The extended MDT meetings include orthopedic, spine, and neurosurgery as well as 
specialized skeletal radiology and genetics consultant input.
This review provides information on the assessment and management of children 
and young adults with OI. It aims to demonstrate how a specialist and an MDT are 
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integral to providing a high-quality service that focuses 
not only on the patient’s condition but also on the broader 
determinants of health and the priorities of care as directed 
by the children and their family.
OI
OI, often referred to as brittle bone disease, is a rare bone 
disorder characterized by bone fragility (fracturing with 
little-to-no trauma), short stature, long bone deformities, bone 
pain, low muscle mass, persistently blue sclera (in some), 
and hypermobility.1 The prevalence of OI is estimated at 1 
in 10,000 new births.2 OI is described as a collagen disorder 
with most causative genetic mutations disrupting collagen 
biosynthesis.3 It can be inherited (autosomal dominant/auto-
somal recessive) or occur spontaneously (de novo/mosaic 
mutation) and is a condition with wide variability in pheno-
typic expression.4,5 Classification of OI follows on from the 
seminal work of Sillence et al6 in 1979 in which they classified 
OI into the following four distinct types: type 1 (mild), type 
2 (lethal), type 3 (severe with progressive deformity), and 
type 4 (moderately severe). These four types are most often 
described in the literature and are attributed to the involve-
ment of the pro-alpha-1 and pro-alpha-2 polypeptide chains 
of type one collagen (Table 1).5,7
Medical management
Physician
The physician is often the first point of contact for referrals 
of patients with OI. The initial role of the physician is to cor-
rectly identify OI and exclude other metabolic bone diseases 
resulting in bone fragility (the commonest reason for referral) 
such as idiopathic juvenile osteoporosis, hypophosphatasia, 
and other rare conditions. Assessment in the clinic should 
ideally be multidisciplinary with the nurse, physical therapist, 
and occupational therapist in attendance, allowing each team 
member to make an appropriate contribution. The physician 
should then ensure that the correct baseline investigations 
are undertaken and a management plan put in place. The 
predominant pharmacological interventions are analgesics 
and bone-targeting treatments such as bisphosphonates. 
Other medical problems consequent on immobility, such 
as constipation, will also require appropriate management.
Decisions on bisphosphonate initiation take into account 
the severity of the patients’ condition, their age, and ability 
to manage either oral or intravenous administration. The 
decision regarding the type of bisphosphonate is made 
with parents, and dose frequency is initially 3 months for 
intravenous therapy (either pamidronate or zoledronic acid) 
and weekly for risedronate, given orally; children receiving 
oral bisphosphonates are seen every 6 months. Modifica-
tion of dose is made on an individual basis, according to the 
response to treatment. Where patients prefer, some or all of 
the infusions can be given closer to home, but monitoring is 
undertaken in Sheffield.
Bisphosphonates are known to increase bone mass, improve 
vertebral size and shape, and in some studies have reduced the 
frequency of fractures.8,9 The efficacy of bisphosphonates in 
reducing fracture frequency may reflect the extent to which 
the increase in bone mass and improved bone architecture 
consequent on their use can offset the altered material proper-
ties of the bone tissue itself. There are anecdotal reports that 
bisphosphonates reduce bone pain, and certainly a consistent 
report from patients under our care is that they “slow down” 
and “ache more” when their next course of treatment is due.
The duration of bisphosphonate therapy and the titration 
of dose against either measurements of bone mass or bone 
turnover markers or the appearance of the vertebrae remain 
the subject of debate. There is considerable variation in prac-
tice between individual units, reflecting the uncertainty that 
exists and the lack of clear evidence to support any single 
specific approach.
New treatments using agents already in clinical use in 
postmenopausal and glucocorticoid-induced osteoporosis 
are finding their way into clinical trials of OI. A trial of 
denosumab in children started in Spring 2015, and a trial of 
parathyroid hormone (essentially ineffective) in adults with 
OI has also been reported. Other treatments are in develop-
ment, and it is likely that further research will be needed to 
assess the impact and cost-effectiveness of these treatments 
compared to the existing approaches.
Orthopedic surgeon
Fracture management is the mainstay of orthopedic interven-
tion in children and young adults with OI.10 Fracture manage-
ment includes the stabilization of acute fractures (generally 
managed by local teams, although more complex fractures 
may warrant transfer to Sheffield Children’s NHS Founda-
tion Trust (SCH) for specialist care) and/or the prophylactic 
correction of deformity to reduce fracture risk.11 
In our experience, corrective surgery can support ambula-
tion by improving range of movement (eg, in the correction of 
coxa vara) and establishing better joint congruence through 
lower limb alignment. Similar outcomes are reported by 
the literature.12,13 Intramedullary rodding, using either non-
telescopic rods (Rush rods, Kirschner wires) or telescopic 
rods (Sheffield rods, Fassier–Duval rods), is used for this 
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Table 1 OI genotypes and phenotypes
Gene Protein/area Phenotype(s)
Collagen molecule
COL1A1 COL1A1 Mild–lethal OI52
High bone mass in C-propeptide cleavage site defects53
Caffey disease with defect at, p.Arg1014Cys54
COL1A2 COL1A2 Mild–lethal OI52
High bone mass in C-propeptide cleavage site defects53
Type I collagen folding
PPIB Cyclophilin B Moderate–lethal OI55
LEPRE1 P3H Severe–lethal OI56
CRTAP CRTAP Severe–lethal OI,59 Cole–Carpenter features59,81
Collagen stability
FKBP10 FKBP65; 65kD FK506-binding protein Moderate–severe OI, Bruck syndrome (OI with contractures),59 
Kuskokwim syndrome (contractures alone)60
PLOD2 LH2 Bruck syndrome61
SERPINH1 HSP47 Severe OI, pyloric stenosis, skin bullae, renal stones62
SPARC SPARC; osteonectin Notable sarcopenia63
Collagen processing/cleavage
BMP1 BMP 1; Tolloid High bone mass, hyperosteoidosis64
Wnt-signaling pathway
WNT1 Wingless-type MMTV integration site family, member 1 Homozygous – severe OI; some have brain malformation, some have 
autism and some have learning difficulties.65
Heterozygous – early onset osteoporosis, normal growth66
Mineralization regulation
SERPINF1 PEDF Slowly progressively worsening OI, osteoid mineralization defect without 
endochondral defect67
IFITM5/BRIL IFITM5 or BRIL Severe OI, metaphyseal dysplasia and sclerosis, hypertrophic callus, 
interosseous membrane calcification68–70
Osteoblast lineage
SP7/OSX Sp7; Osterix Typical OI features71
ER related
P4HB P4H; PDI Cole–Carpenter syndrome, craniosynostosis, ocular proptosis, 
hydrocephalus72
TMEM38B TRIC-B Severe osteopenia and limb fractures without vertebral fractures73
CREB3L1 OASIS Severe OI, cardiac failure74
SEC24D Component of COPII complex Cole–Carpenter syndrome, craniosynostosis, ocular proptosis, 
hydrocephalus75
SPARC SPARC Fragility worsens with age: similar to SERPINF1 defects63
Golgi membrane
MBTPS2 X-linked disease76
Linker enzyme deficiency
XYLT2 XYLT2 Vertebral fractures, cataracts, heart defects77
Bone fragility, not clearly OI
NBAS NBAS Early onset osteoporosis, recurrent acute liver failure, developmental 
delay78
LRP5/6 LPRP5/6 Homozygous – osteoporosis pseudoglioma syndrome79
Heterozygous – osteoporosis and/or vitreoretinopathy80
PLS3 PLS3 X-linked early onset severe osteoporosis without other OI features66
Abbreviations: OI, osteogenesis imperfecta; ER, endoplasmic reticulum.
procedure. The benefit of one over another is subject to 
much debate.14–18 However, there is general consensus that 
telescopic rods are preferable for rodding the lower limbs of 
a growing child; a telescopic rod has greater longevity, thus 
reducing the number of surgeries required.
Orthopedic intervention is also required in the manage-
ment of leg length discrepancy. Leg length discrepancies, 
associated with recurrent fractures and/or lower limb defor-
mity, can impair function, increase back pain, and influence 
scoliosis progression. It is best practice to correct any leg 
length discrepancy as a preventative measure, be this with 
orthotics or orthopedic intervention (epiphysiodesis), to 
guide growth. Occasionally, the application of an Ilizarov 
frame is required to correct deformities and/or stabilize 
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fractures, although this is not a procedure we see often in 
Sheffield.19,20
Spinal complications, including kyphosis, scoliosis, 
spondylosis, and spondylolisthesis, are common problems 
in children and young adults with OI and require regular 
monitoring to enable timely referral to an orthopedic spi-
nal service.21 Management includes exercise, bracing, and 
surgery, although the best course of treatment continues to 
be debated.22,23 Any patient undergoing surgery would be 
reviewed by experienced anesthetic staff and further inves-
tigations determined based on their assessment. Pulmonary 
function is assessed prior to scoliosis surgery, but not prior 
to routine surgery for osteotomy and rodding.
Neurosurgeon
Hydrocephalus can occur early, even in those infants where 
the sutures have not fused. Regular measurement of head 
circumference should be undertaken in infants with OI. 
Clinical features of hydrocephalus are the same as those seen 
in those without OI – vomiting, lethargy, and headache with 
increased head circumference; “sun-setting” of the eyes; 
dilatation of scalp veins; and sutural diastasis. Diastasis 
due to hydrocephalus can be difficult to distinguish from 
poor skull vault mineralization in infants with severe OI. 
Hydrocephalus can also occur later due to herniation of the 
cerebellar tonsils.
Basilar invagination (BI) presents later in childhood; it 
can cause significant neurological difficulties and may be 
difficult to identify. The common signs are headache, nausea, 
lower cranial nerve dysfunction, paresthesia, ataxia, and 
nystagmus. It is radiologically evident on lateral skull radio-
graphs as a progressive upward advance of the odontoid peg. 
Cord signal change on MRI indicates impending or existing 
cord damage. BI is very rare in mild OI; our current practice 
is to perform foramen magnum-centered radiographs annu-
ally in moderately and severely affected patients to assess 
the relationship of the odontoid peg with the skull base and 
only investigate in mild cases where clinical signs are sug-
gestive. Where concern over BI persists, MRI scans are also 
undertaken annually.
CNS
The main role of CNS is to coordinate patient care, ensur-
ing that the services provided meet the unique needs of an 
individual and his or her family.24 CNS provides a crucial 
element of support, facilitating the admission process and 
liaising with patients, families, and other services in respect 
of broader care-related issues.
The CNS works closely with the therapy staff to provide 
handling and feeding support during early years. They coor-
dinate dental appointments with treatment admissions with 
our associated specialist dental hospital in order to maximize 
proper dental care. As a child moves toward adolescence, 
the CNS drives the transition pathway. In Sheffield, we run 
monthly adolescent clinics for young people older than 
12 years. The CNSs are integral to delivery of this program, 
which aims to not only help young people gain the knowledge 
and skills to manage their OI but also help them feel happier 
and more confident about the move to adult services. We 
have established close links with our adult partners at the 
Northern General Hospital in Sheffield but will also refer 
to other centers with expertise in the management of OI. 
Transition clinics run quarterly with both the pediatric and 
visiting adult consultants. Our adult partners offer a clinic 
dedicated to the needs of young people with OI, ensuring 
continuity of care and support.
CNSs also play a key role in the education of patients 
and families and provide support to ward staff and students. 
Where agreed with parents, the CNSs provide education to 
schools. CNSs ensure that written advice and recommenda-
tions are pertinent to the needs of the child. As a team, we 
work in collaboration with the Brittle Bone Society and the 
Paediatric Osteogenesis Imperfecta National Team (POINT) 
to provide support and trusted advice and information across 
services. Patients, families, carers, and local health profes-
sionals are encouraged to use these resources.
Therapeutic strategies
The literature surrounding therapy interventions, including 
physical therapy and occupational therapy, recognizes the 
importance each specialty has in enhancing function and 
independence for children with OI.25,26 The long-term goal 
is that children live independently and develop the life skills 
to enable them to direct their own care.21
Assessment and intervention at SCH includes inpatient, 
outpatient, and intensive therapy sessions. As outpatients, 
children are reviewed at least once a year in Sheffield or 
for those under the auspices of the HSS, in outreach clin-
ics across the north of England; inpatients are reviewed at 
each admission. Community visits to home and school are 
undertaken across the region. Intensive therapy sessions 
involve a 5-day admission to SCH where children are seen 
two-to-three times daily.
Outcome measures are used in all of these settings. The 
Brief Assessment of Motor Function (BAMF) and the OI 
Pediatric Specific Quality of Life Questionnaire (OI qual) 
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have been found to be valid and reliable.27,28 In addition to 
ease of application, both of these outcome measures are 
useful tools in the clinical setting. The Gross Motor Func-
tion Measure (GMFM), reliable in OI, has been used with 
some success. However, as with many outcome measures, 
difficulties can arise with more severe patients.29 At SCH, the 
Bayley Scales of Infant and Toddler Development, Movement 
Assessment Battery for Children and the Detailed Assess-
ment of Speed of Handwriting (DASH) have been used in 
assessment and treatment planning. Although not valid or 
reliable in the OI population, these outcome measures have 
proven valuable in supporting a child’s needs.30–32
Physical therapy and occupational therapy interventions 
include muscle strengthening; prevention of joint contrac-
tures; prevention of malalignment; improvement in function, 
including personal activities for daily living; transfers and 
ambulation; and modification and graded performance of 
everyday tasks.25,33,34 The therapy team supports children with 
OI to overcome the many obstacles to independent living, 
encouraging and respecting their individual problem-solving 
approaches.
Occupational therapy and physical 
therapy
Babies and toddlers
In infants, positioning, handling, and transportation require 
considerable therapy input.35 Therapy ensures appropriate 
handling and support to minimize fracture risk, promote good 
alignment, and prevent worsening of deformities. In Sheffield, 
it is our practice to handle severe OI babies in supine, increas-
ing their angle of incline over the first 2 years of life. The 
benefits of this approach are yet to be demonstrated in pro-
spective longitudinal studies. However, clinical experience 
suggests that by handling severe OI babies in this way, their 
risk of crush fractures, kyphosis, and/or scoliosis is reduced. 
Complications associated with prolonged supine positioning, 
such as brachycephaly and plagiocephaly, can be addressed 
by establishing a routine with parents/carers that encourages 
frequent head turns and side and, when appropriate, prone 
lying. The provision of fabric rolls, wedges, and “book ends” 
(fabricated from splinting material) to maintain these posi-
tions can be key in ensuring the success of the routine. The 
cephalic index is measured at each admission in the first year 
of life to monitor brachycephaly and plagiocephaly. To pro-
mote cognitive development, parents/carers are encouraged 
to stimulate their baby through play; therapists offer advice 
on appropriate toys and activities. Parallel to this, the sup-
port of a clinical psychologist to track a baby’s development 
ensures timely onward referral to specialist child develop-
ment services as required.
Parents/carers are shown how to lift their baby for 
transportation, nappy changing, bathing, and dressing. 
Car seats that are “lay flat” or have a maximum recline are 
recommended. Prams should have a “lay flat” option, pref-
erably with wheeled suspension. Bathing is recommended 
in a standard baby bath padded with a thick towel or foam 
support; the shallow water provides just enough buoyancy 
to encourage movement and kicking of the lower limbs. 
Clothing should minimize the pushing and pulling of limbs; 
items that open out fully along the torso, arms, and legs are 
preferable. Lightweight cotton clothing is recommended as 
synthetic fabric can exacerbate sweating, a common feature 
in this patient group.
We experience that toddlers, even with the mildest forms 
of OI, may have some delay in reaching key motor milestones, 
owing to hypermobility and/or recurrent fractures. Therapists 
facilitate the acquisition of gross motor skills progressively 
through play, the use of specialist equipment and functional 
tasks. Strategies focus on improving functional ability and 
developing self-care and independence skills. Toddlers are 
supported to first develop gross motor skills such as sitting 
and reaching and then progress to toileting, washing, dress-
ing, and feeding. Despite careful assessment and intervention, 
planning, anxiety and fear of fracture, and movement can 
potentially create a barrier to the attainment of motor skills. 
Young children who experience recurrent fractures and/or 
surgery often delay in developing self-care tasks such as 
toileting; toddlers often resort to nappies when recovering 
from fracture/surgery. Consequently, acquisition of self-care 
skills may take longer than that in the general population. 
For more severely affected children, independence can be 
achieved with perseverance and the use of modified/special-
ized equipment; standard products are often too big, limiting 
comfort, stability, and accessibility.
Standing frames are not routinely used by the Metabolic 
Bone Team at SCH; they are not well tolerated due to bowing 
deformities and risk of fracture. Rather, therapists consider 
manual facilitation, regular stretches of muscle groups at risk 
of shortening (hip flexors/Achilles tendon), exercises that 
promote gross motor skills and improve strength and stabil-
ity, appropriate walking aids such as the Kingcraft walker 
(developed in Sheffield), orthoses to support foot posture, 
and appropriate individualized wheelchair provision.
At SCH, we consider wheelchair provision as early as 
18 months old, commensurate with developmental milestones 
for ambulation. Consequently, children are supported and 
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encouraged to explore their environment, facilitating cogni-
tive development in line with their peers. For some, this may 
be a short-term intervention, with ambulation the long-term 
goal, especially in the more mildly affected individuals. For 
more severely affected children, the wheelchair is often their 
main form of mobility. Lightweight, “active user” wheel-
chairs such as the Panthera Micro maximize independent 
mobility for younger children; an abducted frame will support 
independent transfers. Young children should be provided 
with appropriate sized wheelchairs and not wheelchairs “to 
grow into”; an oversized wheelchair not only impairs function 
but may also encourage/exacerbate deformity.
Children
Children acquire skills, make friends and develop a sense 
of meaning and purpose in life through participation.36 
However, many children with OI struggle with “being safe 
and careful, reduced function, pain, fear, independence, and 
isolation”.37 Consequently, they find participation at home, 
at school, and in the wider community difficult. To ensure 
inclusion is a reality for these children, therapists should 
consider the important principles of energy conservation, 
positioning, and joint protection in addition to mobility and 
environmental access. At SCH, the goals of childhood are to 
improve strength, stamina, and mobility; to progress self-care 
skills; and to have fun being active.
For those more severely affected children, short stature 
and bowing deformities make performing everyday tasks 
such as transfers, washing, and dressing problematic. Chil-
dren with type V OI often struggle with restricted elbow 
range of movement owing to calcification of the interosseous 
membrane and dislocation/subluxation of the radial head. 
This can make activities such as hair washing/brushing and 
bottom wiping difficult. At home and school, the provision 
of aids and adaptations can help children achieve indepen-
dence. While extensive structural changes may sometimes be 
required, for example, ground floor wet room facilities, other 
accessibility problems can be addressed with simple assistive 
devices, for example, bath seat, grab rail, and wide shallow 
steps. At school, children may need disabled toilet facilities 
for ease of access; facilities can include toilet handles and 
frames, transfer plinths, or the addition of toilet chairs such 
as the Heathfield potty chair. Simply rearranging classroom 
seating/furniture and equipment can improve access and 
support participation.
The importance of providing appropriate wheelchairs and 
seating should not be underestimated.38 Assessment considers 
joint protection and prevention of bony deformity in addition 
to postural alignment principles. Each wheelchair and seating 
system should meet individual needs and is dependent not 
only on the child’s limitations but also on their environment 
and the context in which they live.39 At SCH, primary school-
aged children are encouraged to use manual wheelchairs such 
as the Panthera Micro or Zippie Simba, to maintain activity 
levels and fitness.
Seating provisions range from simple anterior tilt cush-
ions and foot boxes for the mildly affected children to chairs 
offering hi–lo, tilt-in-space options for children requiring 
higher levels of postural control and protection. Children 
who require high levels of postural control are also given 
regular stretches, for example of the hip flexors, to prevent 
joint contractures. Home exercise programs that promote 
strength, for example, of the abdominal/spinal muscles, fit-
ness, and independence are also encouraged.
Regardless of severity, muscle weakness is a common 
complaint for those who have OI. Whether this weakness is 
indicative of OI or a result of the sedentary lifestyle often 
adopted by this patient group, it can impact upon a child’s 
everyday life.40–42 Van brussel et al43 found that a supervised 
exercise training program (twice weekly for 12 weeks) can 
have a positive impact, not only on a child’s strength but 
also on his or her exercise and maximal working capacity. 
While the delivery of such a program is often untenable in 
clinical practice, individualized exercise programs can be 
integrated into daily life with the support of local therapists, 
schools, and parents/carers. Often, the most successful exer-
cises are those that are meaningful and target more than one 
outcome, for example, baking from a perching stool rather 
than a wheelchair to work toward standing. This “exercise” 
requires lower and upper limb strength, proprioception and 
balance, coordination, planning, and fine motor manipulation. 
Baking and similar functional tasks are often used as part 
of the intensive therapy sessions at SCH; the importance of 
play and using fun activities as part of therapy should not 
be underestimated.
When devising an exercise program for a child with OI 
therapists, consider the mechanical strain and muscle force 
acting upon the bone, particularly in children with bony 
deformity and associated loss of joint range. Hydrotherapy 
can be effective in promoting strength and facilitating/main-
taining range of movement, especially following orthopedic 
intervention. Hydrotherapy should always be used in conjunc-
tion with a land-based program, as weight bearing through 
bone is essential in promoting bone strength.44,45
Often children with OI are discouraged from participating 
in sport due to risk of fracture or decreased mobility. While 
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sports that significantly increase forces through the spine 
(trampolining, sledging, horse riding) are not recommended, 
with reasonable adjustments and careful consideration of 
the environment, children can participate in many activities 
alongside their peers. Schools often require the support of 
the therapy team to include children with OI in physical 
education. Therapists advise on suitable activities, provide 
individual exercise plans and suggest equipment adaptations. 
They work with schools to encourage the child to build a 
positive relationship with sport and exercise.
Ligamentous laxity/hypermobility, a common feature of 
OI, can have a significant impact on participation. Hyper-
mobility can be generalized or extreme at specific joints.46 
Children with hypermobility can lack strength and stamina 
to perform gross and fine motor activities. The interventions 
include muscle strengthening, advice on pacing activities 
and provision of assistive devices such as pencil grips and 
lycra gloves. Children with hypermobility often complain of 
fatigue. Fatigue, which can be overwhelming, may also be 
related to bone pain and poor sleep patterns. Children with OI 
regularly complain of “overheating” at night time. Appropri-
ate mattress provision, which reduces the heat transfer rate 
between the child and the support surface, is recommended.
Adolescents
Adolescence can be a challenging time for all, especially 
those with chronic health conditions. Maintaining a regular 
review of young adults in the appropriate setting such as an 
adolescent clinic is important.47 Therapists work collabora-
tively with CNS to encourage and support adolescents to take 
responsibility for function, adjustment and well-being in all 
domains of life. The transition program implemented by the 
Metabolic Bone Team at SCH supports this goal. 
The move to secondary school and college can herald 
many functional challenges. For mildly affected adolescents, 
manual wheelchairs can provide a means of pacing activity 
throughout the school day. More severely affected adolescents 
will require a powered wheelchair with an elevating seat to 
access a larger school campus and promote independence in 
the wider community. In addition to mobility aids, students 
are supported to move independently around school with 
reasonable adjustments, for example, lift access, leaving les-
sons early, etc. As academic demands increase, it is important 
for young people to develop compensatory and/or adaptive 
strategies to allow them to fulfill their academic potential; 
consider dictation software, scribe, and extra time.
Specialist seating provision can be complex at the sec-
ondary level owing to multiple classroom uses. Students 
may be allocated one specialist chair with a hi–lo facility 
(eg, Neptune, Wombat, Vela Tango) to be shared across a 
variety of lessons; ergonomic and environmental assessment 
is hence a prerequisite to maximize function. Stool seating in 
science, design and technology, and art should be reviewed, as 
adolescents with OI often require a back support and educa-
tion regarding good spinal posture; ligamentous laxity and 
muscle weakness can place increased demands on the spinal 
muscles to maintain normal joint alignment.
Hypermobility, muscle weakness, long bone deformity, 
and joint contractures, with the associated loss of movement, 
all continue to be problematic for adolescents with OI. In 
devising an exercise program, the interests of the patient are 
an important consideration. A number of adolescents at SCH 
have been keen to participate in mainstream fitness activities 
and sports as these can be enjoyed alongside peers. However, 
access can sometimes be difficult owing to both the physi-
cal environment and health and safety concerns. Therapists 
provide advice on appropriate adjustments. At SCH, we offer 
young adults living locally the opportunity to have supervised 
gym sessions with a therapist.
Throughout adolescence, young people living with OI 
are faced with situations that challenge them both physically 
and emotionally. Although therapists are key in supporting 
their needs, the coordinated efforts of the MDT, including 
psychology and social work, are integral to their care.
Psychology
Under the HSS for severe, complex and atypical pediatric 
OI, at SCH, the clinical psychologist would routinely see all 
new babies and their families within the first few months of 
life. Early support and intervention can enhance attachment 
and bonding using tools such as the Newborn Behavioral 
Observations Assessment.48
As children grow, they are faced not only with physical 
but also with social and emotional demands. Psychological 
well-being can be affected as children find themselves in 
unfamiliar and unwanted situations, resulting in distress, 
anger, sadness, and anxiety. Consequently, parents/carers 
may find it difficult to manage both their child’s emotional 
response and their own reaction to their child’s presentation.49 
The clinical psychologist is able to offer general support in 
addition to targeted anxiety and behavioral management strat-
egies to these families in need. Regular monitoring with each 
admission ensures timely onward referral to local services.
While children with OI have the same aspirations as other 
children and young people, they may need additional help to 
achieve their goals. They often report feeling isolated and may 
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have feelings of being “different”. Some may fear needles 
and/or operations and some may feel depressed or even fear 
early death.31,50 The clinical psychologist supports children 
with OI and their families with these issues, including the 
emotional consequences of living with chronic disease and 
the impact that they can have on their and their family’s life.51 
Balancing the care of a child who has OI with the needs of 
other family members can lead to fatigue, stress, and sadness. 
This may impact on the health and relationships of parents/
carers and siblings. By working closely with the broader 
team, the psychologist can identify children and families 
likely to be at increased risk of developing psychological 
difficulties in order to offer preventative intervention. This 
may be onward referrals to local Child and Adolescent Men-
tal Health Service, telephone consultations or group or 1:1 
consultations as appropriate.
In Sheffield, the clinical psychologist also takes a lead 
on cognitive assessment and monitoring when concerns 
regarding development are raised. In conjunction with assess-
ments completed by other team members, developmental 
tracking enables timely onward referral to specialist child 
development services as required. A multiagency working 
with education, social care, and other services in-line with 
assessment enables adequate support to be implemented for 
children with additional learning needs.
In addition to working directly with children and families, 
the clinical psychologist can provide consultation to team 
members to ensure profession-specific interventions meet and 
are appropriate for the psychological needs of the children 
and their families.
Speech and language therapists and 
dieticians
Although specialties in their own right, speech, and language 
therapists (SALTs) and dieticians complement each other and 
play an important role in the management of children with OI.
Dieticians are experts in nutritional assessment and 
care. They can suggest dietary modifications and develop 
nutritional care plans to help babies and children develop a 
healthy lifestyle diet that supports optimal bone mass, devel-
ops muscle strength, and avoids obesity. The Sheffield team 
members encourage and support mothers to breast or bottle 
feed their OI babies. Nasogastric tube feeding and percutane-
ous endoscopic gastrostomy (PEG) are used only in extreme 
circumstances. The more severely affected babies can be 
poor feeders: they may have a weak sucking reflex, gastric 
reflux, or respiratory problems.50 There is also the added 
complication that mothers are advised to nurse their babies 
in a supine position. While this may sometimes be difficult, 
the SALT and the dietician assist by developing strategies 
to improve feeding. They work collaboratively to provide a 
balanced nutritional diet with a variety of food textures to 
reduce the likelihood of oral defensiveness.
Complications can arise for babies and children with 
OI owing to their small stature, difficulties in breathing and 
swallowing in the neonatal period (severe babies), limited 
mobility and low appetite (particularly at times of fracture/
surgery and for those children experiencing chronic pain). 
The dietician provides advice on the size and frequency of 
feeds to ensure that slow growth is not mistaken as a failure to 
thrive. Unlike other skeletal dysplasia such as achondroplasia, 
there are no disease-specific growth charts for babies with OI. 
In the very young adults, this can lead to inaccurate assess-
ment of growth and weight gain, often leading to increased 
stress and anxiety for parents/carers.
Children and young adults with OI should be encour-
aged to eat a balanced diet that is low in fat, salt, and added 
sugar and contains a variety of vitamins and minerals.50 They 
often struggle with constipation, which can be attributed to 
short stature, inactivity, pelvic asymmetry, and dehydration. 
Some children avoid defecation away from home owing to 
practical difficulties and inconvenience.51 A high-fiber diet 
that includes plenty of water/fluids and physical activity can 
help alleviate this problem. This requires a coordinated treat-
ment plan from the dietician, physiotherapist, occupational 
therapist, psychologist, pediatrician, and family.
Obesity is a risk in children and young adults with OI. In 
addition to the extra stress placed on the skeleton, obesity may 
interfere with rehabilitation and can lead to other health com-
plications. Dieticians work at the primary health promotion 
level, educating children and families living with OI about 
high nutrient, low fat foods, and the importance of portion 
control. Working closely with the wider team, the dietician 
is able to calibrate diet to age, size, and levels of activity.
Social worker
Psychosocial assessment and intervention form part of the 
treatment plan for children with OI. There are many issues 
involved in caring for a person with OI that are not medical, 
for example, housing, education, funding for equipment, 
social support, and benefits. This is in addition to coping 
with and adjusting to living with a lifelong condition. Rel-
evant information about psychosocial functioning is shared 
with the MDT as appropriate. This helps to ensure that the 
emotional and practical support the whole family needs is 
considered in planning.
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Following diagnosis, families can become stressed due to 
the complicated nature and lifelong effects of the condition. 
Social workers provide families with trusted information and 
resources to help them plan for and take care of their child. 
They partner with families to advocate for their child both 
in and out of the hospital. They provide essential support to 
access financial assistance, benefits, and charity claims and 
applications. Social workers ensure that families access all 
the benefits, charities or local authority resources for which 
they are eligible. This can include practical support such as 
local activities, flexible short breaks, direct payments, or 
holidays. Social workers aim to ensure that the social aspect 
of a family’s life is impacted as little as possible by their 
child’s medical diagnosis.
Social workers liaise with medical teams and other local 
authorities in the identification and response to child protec-
tion concerns. They support other members of the MDT in 
identifying and referring child protection concerns to the 
relevant departments. This is always alongside referrals for 
support when children and family are in need.
Summary
Management of children and young adults with OI is complex 
and challenging due to the heterogeneity both across and 
within the different types. There is no single intervention or 
plan that can meet the needs of all. Best practice requires the 
input of an MDT delivered within a setting of a pediatric bone 
unit. The focus of interventions should be not only on the 
condition but on the broader determinants of health as well. 
By working collaboratively, children and young adults with 
OI are supported to improve health and quality of life, family 
and social participation, and academic achievement. Within 
the MDT, mutual respect, communication and specialist skills 
are required to deliver a gold standard of care. With joint 
working patterns, the MDT shares knowledge and expertise, 
delivering holistic treatment plans. Feedback from patients 
indicates that the MDT approach facilitates and enhances a 
sense of partnership, friendship, and support for OI families.
Practice points
Bisphosphonates and surgical intervention, supported by 
therapeutic strategies, improve function and quality of life 
in children and young adults with OI.
•	 Best practice is achieved through working of MDT, 
delivered in a specialist pediatric bone center.
•	 Aims of treatment are to maximize function, indepen-
dence, and well-being, providing the child and young 
adult with life skills to direct their own care.
•	 Accessing accurate information about the condition can 
be helpful in establishing working relationships. Patients, 
families, and those involved in the care of a child with 
OI should be encouraged to access the POINT leaflets 
and web-based information source supported by charities 
such as the Brittle Bone Society.
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